These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4149623)

  • 1. Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.
    Tobias LL; MacDonald ML
    Psychol Bull; 1974 Feb; 81(2):107-25. PubMed ID: 4149623
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance psychotropic drugs in the presence of active treatment programs. A "triple-blind" withdrawal study with long-term mental patients.
    Paul GL; Tobias LL; Holly BL
    Arch Gen Psychiatry; 1972 Jul; 27(1):106-15. PubMed ID: 4555827
    [No Abstract]   [Full Text] [Related]  

  • 3. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H; Müller-Oerlinghausen B
    Arzneimittelforschung; 1974 Jul; 24(7):976-80. PubMed ID: 4603668
    [No Abstract]   [Full Text] [Related]  

  • 4. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H; Chien CP; Cole JO
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
    Gilbert PL; Harris MJ; McAdams LA; Jeste DV
    Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    Tanghe A; Vereecken JL
    Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564
    [No Abstract]   [Full Text] [Related]  

  • 9. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM; Mielke DH; Spirtes MA; Swanson WC; Bost R
    Am J Psychiatry; 1974 Jun; 131(6):699-702. PubMed ID: 4597305
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia.
    Toru M; Shimazono Y; Miyasaka M; Kokubo T; Mori Y; Nasu T
    J Clin Pharmacol New Drugs; 1972; 12(5):221-9. PubMed ID: 4555882
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment patterns in psychiatry: relationships to symptom features and aging.
    Fracchia J; Sheppard C; Merlis S
    J Am Geriatr Soc; 1973 Mar; 21(3):134-8. PubMed ID: 4144996
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychological effects of single-dose antipsychotic medication.
    Serafetinides EA; Clark ML
    Biol Psychiatry; 1973 Dec; 7(3):263-7. PubMed ID: 4586833
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.
    Prien RF; Cole JO; Belkin NF
    Br J Psychiatry; 1969 Jun; 115(523):679-86. PubMed ID: 5806858
    [No Abstract]   [Full Text] [Related]  

  • 15. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 17. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients.
    Small JG; Kellams JJ; Milstein V; Moore J
    Am J Psychiatry; 1975 Dec; 132(12):1315-7. PubMed ID: 1106217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 19. The neuroleptics. 8. Clinical methodology.
    Ban TA; Bordeleau JM; Debray HR; Hamilton M; Ito H; Overall JE; Pichot P; Reda G; Tetreault L; Volmat R; Wiart C
    Mod Probl Pharmacopsychiatry; 1970; 5():133-40. PubMed ID: 4949817
    [No Abstract]   [Full Text] [Related]  

  • 20. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.